| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |